STAT3 and colorectal carcinoma: Indeed, intravenous injection of the STAT3 inhibitor BP‐1‐102 into a mouse model of sporadic CRC decreases TIL‐induced activation of NF‐κB and STAT3 and thus CRC cell proliferation [35].